Specifically designed by the Society for Immunotherapy of Cancer (SITC), the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CNE- and CPE-certified programs, presented by leading, local authorities in tumor immunology and cancer immunotherapy.
These six-hour programs will:
- Facilitate your understanding of the clinical applications of immunotherapy for disease states with FDA-approved treatments
- Provide strategies for overcoming operational and reimbursement barriers to implementing immunotherapy in a community setting
- Offer support in the identification and management of immune-related adverse events
Attendees will also have an opportunity to connect with regional experts in the immunotherapy field during the in-person event, in two post-program webinars and through a dedicated online SITC CONNECT community forum.